Gail Wilensky PhD, senior fellow at Project HOPE, addresses the shift to value-based care over the years and what can be done to keep moving forward.
Gail Wilensky PhD, senior fellow at Project HOPE, addresses the shift to value-based care over the years and what can be done to keep moving forward.
Transcript
Have you seen progress in the shift to value-based care in the recent years? What efforts do you think are needed to accelerate this shift?
I’ve been very disappointed at how hard and how slow it’s been to shift to value-based care. I think several things are going on. We have too many metrics being used; I think we need to drastically consolidate the number of metrics. It would be helpful to have a smaller set used by various payers not each individual payer coming up with their own and a smaller set at that. It’s clearly harder than we thought it would be to be able to move the needle on this.
I also think it would require that much more the reimbursement be put at risk. You can’t expect, particularly, clinicians to respond to an incentive that has quite small effect on their overall reimbursement, either because it’s a very small percent of the overall reimbursement or they, as a particular type of clinician, don’t have very many of those patients. The institutions, the hospitals seem to respond with relatively small changes, although if you really want to get their attention, you ought to increase that, as well. So, we need to keep at it.
The notion of paying as though quality didn’t differ dramatically and efficiency and price didn’t differ dramatically across different institutions is just wrong. We just haven’t figured out how to get it right yet.
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Ways Providers, Payers Can Ensure Biomarker Testing Is Done in Cancer Care
October 18th 2024There is a role for both payers and providers to make small changes that would increase the use of biomarker testing to ensure patients are receiving the appropriate treatment, said Susan Wescott, RPh, MBA, senior director of managed care pharmacy, Mayo Clinic.
Read More